Leadership, Education & Groundbreaking Regenerative Medicine – Prof. Pamela Habibović
Biomed UnleashedShow Notes
What does it take to guide scientific research and higher education at one of the world's best young universities?
In this inspiring conversation, we speak with Professor Pamela Habibović, Rector Magnificus of Maastricht University and co-founder of the MERLN Institute for Regenerative Medicine in Maastricht, the Netherlands.
The conversation touches on many turning points in her career: international research experiences, mentoring and leading scientific teams, building and shaping the MERLN Institute, and transitioning from hands-on research to academic leadership. We also discuss how to foster innovation, guide large organizations, and connect research with education and societal needs.
Beyond leadership challenges, Pamela reflects on the evolving role of women in STEM, the value of meaningful publishing, and the importance of celebrating milestones. She shares insights on how to build diverse and creative teams and maintain purpose and impact in large academic institutions.
This interview reveals an academic leader who has not only advanced science but also guided institutions and people – bridging research, education, and societal impact.
If you want to learn more about the institutes mentioned in the episode, please follow the links below:
MERLN Institute for Technology-Inspired Regenerative Medicine – https://merlninstitute.com Maastricht University – https://www.maastrichtuniversity.nl
Timestamps 00:00 – Intro to Biomed Unleashed 00:28 – Meet Prof. Pamela Habibović: Rector Magnificus of Maastricht University and co-founder of MERLN, the Netherlands 01:11 – Let’s dive in 01:24 – From Bosnia to the lab: the childhood moment that sparked her love for science 01:56 – A home filled with minerals and the beauty of curiosity 03:04 – The Philippines internship: seaweed, heavy metals, and an unexpected discovery 04:48 – A power outage that changed everything – when serendipity meets science 05:27 – From technician to scientist: the desire to be involved in the full research process 07:01 – What are osteoinductive materials and why they matter in medicine? 09:18 – “Your project is terrible, but you’re in.” The rejection that changed her career 11:12 – Life in Boston: brilliant minds, extreme competition, and key lessons learned 14:18 – Doing a PhD in a company versus a university: two different worlds 15:52 – McGill University: how the Canadian system compares to the US 17:21 – Why she returned to Europe after her North American experience? 18:17 – Mentorship and moonshots: lessons from Clemens van Blitterswijk – a pioneer in tissue engineering 20:51 – The call that started it all: founding the MERLN Institute for Regenerative Medicine in the Netherlands 23:03 – Building MERLN from the ground up: challenges, vision, and people 24:58 – Rethinking how to organize research: not by organs, but by technology 26:16 – Beyond bone: instructive biomaterials for organoids and tissue regeneration 27:47 – Advice on how to grow as a scientist 30:14 – Publishing for meaning, not for metrics: why content matters more than numbers 34:07 – Why many great ideas stop at early stages and how to bridge that gap 37:21 – The missing link in academia: connecting research with real-world needs 39:43 – Taking leadership at MERLN: from pioneering chaos to sustainable growth 42:16 – The power and challenge of diversity in science 44:45 – Becoming University Rector Magnificus: doubts, motivations, and a vision for change 47:16 – Discovering the bigger picture at the University 52:58 – Building bridges between disciplines: Brightlands and Global Studies examples 54:53 – Advice to her younger self: pause, reflect, and celebrate the milestones 56:56 – Women in STEM: what has changed and what still must change 01:01:02 – Her proudest scientific achievement 01:02:05 – What would she do if not academia – a surprising answer 01:02:55 – Closing thoughts and reflections 01:03:03 – Biomed Unleashed Outro
More from Biomed Unleashed
What does it take to build one of Europe’s leading research institutes in Regenerative Medicine? In this inspiring conversation, we speak with Professor Clemens van Blitterswijk, a pioneer in tissue engineering and founder of the MERLN Institute for Technology-Inspired Regenerative Medicine in Maastricht, the Netherlands. The conversation touches on many turning points: building companies during crises, navigating the choice between academia and business, and leading a remarkable transfer of sixteen colleagues to establish a new research institute. Clemens reflects on the right time to commercialize discoveries and how coincidental findings can lead to breakthroughs in top journals. He shares insights on helping startups through RegMed XB and the delicate art of knowing when to push forward and when to stop. We also discussed why art and science are more closely related than we think. From biomaterials that grow bone to Clemens’ vision for high-throughput technologies, this interview reveals a scientist-entrepreneur who has not only advanced regenerative medicine but also built bridges between universities, startups, and patients – pushing regenerative medicine field forward.
What does it take to lead the future of regenerative medicine? Professor Martijn van Griensven shared the experiences that have shaped his journey from his early days as Germany’s youngest professor to his current work as a leading mind in biomedical research and head of the cBITE department at the MERLN Institute. We explored how bones heal, and why sometimes they don’t, and what role the immune system plays when regeneration breaks down. We dove into the molecular world of RNA therapies and their potential to modulate immune responses and help tissues rebuild themselves. We talked about the practical challenges of bringing these therapies into the clinic, the role of AI in tailoring treatments to each patient, and what the future might hold. For Professor van Griensven, it’s not just about molecules and machines, it’s about curiosity, perseverance, and asking the right questions.
How do you commercialize regenerative medicine, and why is it so challenging? What does it take to build a successful biotech startup? And are revolutionary regenerative medicine solutions closer than we think?
How do you get hold of the viruses and, with their help, cure some of the deadliest diseases known to humanity?
What is personalised medicine and how it revolutionizes our understanding of classic medical approaches?